医薬品リファレンス
Trametinib
Trametinib is a medicine in the class oncology. It is used for melanoma.
- 薬効分類: Oncology
- 効能・効果: melanoma
最終更新日 出典: US FDA label
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
要点
- 薬効分類
- Oncology
- ATCコード
- L01EE01
- 一般的な剤形
- 錠剤, 溶液
- 一般的な規格
- 0.5 mg
- 既知の相互作用
- 1 (軽度: 1)
- 商品名
- 4
- 国・市場
- 3
何に使われるか
作用のしくみ
Trametinib is a reversible inhibitor of MEK1 and MEK2 activation and kinase activity. MEK proteins are upstream regulators of the ERK pathway, which promotes cellular proliferation.
成人の通常用量（添付文書の要約）
Adults, all approved indications (tablets): 2 mg orally once daily, until disease progression or unacceptable toxicity; adjuvant melanoma up to 1 year
妊娠と授乳
- 妊娠
- Unsafe Can cause fetal harm: in rabbits it was embryotoxic and caused abortion at about 0.3 times human exposure; human data are insufficient. Check pregnancy status; contraception during treatment and for 4 months after the last dose (men with female partners: condoms for 4 months).
- 授乳
- Unsafe No human milk data. Highly protein bound, but its half-life of about 4 to 5 days could let it build up in the infant. Do not breastfeed during treatment and for 4 months after the last dose.
報告されている副作用
- Rash
- Diarrhea
- Lymphedema
- Pyrexia
- Nausea
- Vomiting
禁忌
- None.
注意が必要な方
- New primary cutaneous and non-cutaneous malignancies can occur when used with dabrafenib; monitor patients.
- Hemorrhage, including fatal major hemorrhage, can occur.
- Colitis and gastrointestinal perforation can occur.
妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。
主な相互作用 (1)
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Trametinibの完全なモノグラフ（用量、妊娠・授乳、副作用、警告、すべての相互作用）を表示できます。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- How to give it
- Pharmacokinetics
- Patient counselling points
- Food interactions
- IV preparation and dilution
WebでPro+を14日間無料でお試し。カード登録不要。
同じ分類のほかの薬剤
よくある質問
What is Trametinib used for?
Trametinib is a medicine in the class oncology. It is used for Melanoma, Non-small cell lung cancer, Thyroid cancer.
What side effects have been reported with Trametinib?
Rash, Diarrhea, Lymphedema, Pyrexia, Nausea, Vomiting.
Can Trametinib be taken in pregnancy or while breastfeeding?
Pregnancy: Unsafe. Can cause fetal harm: in rabbits it was embryotoxic and caused abortion at about 0.3 times human exposure; human data are insufficient. Check pregnancy status; contraception during treatment and for 4 months after the last dose (men with female partners: condoms for 4 months). Breastfeeding: Unsafe. No human milk data. Highly protein bound, but its half-life of about 4 to 5 days could let it build up in the infant. Do not breastfeed during treatment and for 4 months after the last dose.
What does Trametinib interact with?
MediHelp lists 1 known interactions for Trametinib. Minor: 1. The most serious include Dichlorphenamide.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
